Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 32

1.

Identification of clinically relevant molecular subtypes in colorectal cancer: the dawning of a new era.

Johnston PG.

Oncologist. 2014 May;19(5):568-73. doi: 10.1634/theoncologist.2014-038. Epub 2014 Apr 9.

PMID:
24718513
[PubMed - in process]
Free PMC Article
2.

Biological predictors of survival in stage II colorectal cancer.

Ueda Y, Yasuda K, Inomata M, Shiraishi N, Yokoyama S, Kitano S.

Mol Clin Oncol. 2013 Jul;1(4):643-648. Epub 2013 May 20.

PMID:
24649222
[PubMed]
Free PMC Article
3.

Nanostring-based multigene assay to predict recurrence for gastric cancer patients after surgery.

Lee J, Sohn I, Do IG, Kim KM, Park SH, Park JO, Park YS, Lim HY, Sohn TS, Bae JM, Choi MG, Lim do H, Min BH, Lee JH, Rhee PL, Kim JJ, Choi DI, Tan IB, Das K, Tan P, Jung SH, Kang WK, Kim S.

PLoS One. 2014 Mar 5;9(3):e90133. doi: 10.1371/journal.pone.0090133. eCollection 2014.

PMID:
24598828
[PubMed - in process]
Free PMC Article
4.

The expression of multiple proteins as prognostic factors in colorectal cancer: cathepsin D, p53, COX-2, epidermal growth factor receptor, C-erbB-2, and Ki-67.

Shin IY, Sung NY, Lee YS, Kwon TS, Si Y, Lee YS, Oh ST, Lee IK.

Gut Liver. 2014 Jan;8(1):13-23. doi: 10.5009/gnl.2014.8.1.13. Epub 2013 Aug 14.

PMID:
24516696
[PubMed - in process]
Free PMC Article
5.

SIRT1 Expression Is Associated with Good Prognosis in Colorectal Cancer.

Jung W, Hong KD, Jung WY, Lee E, Shin BK, Kim HK, Kim A, Kim BH.

Korean J Pathol. 2013 Aug;47(4):332-9. doi: 10.4132/KoreanJPathol.2013.47.4.332. Epub 2013 Aug 26.

PMID:
24009628
[PubMed]
Free PMC Article
6.

Expression of E-cadherin and KRAS mutation may serve as biomarkers of cetuximab-based therapy in metastatic colorectal cancer.

Nakamoto K, Nagahara H, Maeda K, Noda E, Inoue T, Yashiro M, Nishiguchi Y, Ohira M, Hirakawa K.

Oncol Lett. 2013 Apr;5(4):1295-1300. Epub 2013 Feb 8.

PMID:
23599782
[PubMed]
Free PMC Article
7.

The potential of carcinoembryonic antigen, p53, Ki-67 and glutathion Stransferase-π as clinico-histopathological markers for colorectal cancer.

He Z, Shi C, Wen H, Li F, Wang B, Wang J.

J Biomed Res. 2010 Jan;24(1):51-7. doi: 10.1016/S1674-8301(10)60008-5.

PMID:
23554611
[PubMed]
Free PMC Article
8.

The impact of chemotherapy-associated neutrophil/ lymphocyte counts on prognosis of adjuvant chemotherapy in colorectal cancer.

Chu-Yuan H, Jing P, Yi-Sheng W, He-Ping P, Hui Y, Chu-Xiong Z, Guo-Jian L, Guo-Qiang W.

BMC Cancer. 2013 Apr 3;13:177. doi: 10.1186/1471-2407-13-177.

PMID:
23551939
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Biologic determinants of tumor recurrence in stage II colon cancer: validation study of the 12-gene recurrence score in cancer and leukemia group B (CALGB) 9581.

Venook AP, Niedzwiecki D, Lopatin M, Ye X, Lee M, Friedman PN, Frankel W, Clark-Langone K, Millward C, Shak S, Goldberg RM, Mahmoud NN, Warren RS, Schilsky RL, Bertagnolli MM.

J Clin Oncol. 2013 May 10;31(14):1775-81. doi: 10.1200/JCO.2012.45.1096. Epub 2013 Mar 25.

PMID:
23530100
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Bax expression is a candidate prognostic and predictive marker of colorectal cancer.

Katkoori VR, Suarez-Cuervo C, Shanmugam C, Jhala NC, Callens T, Messiaen L, Posey J 3rd, Bumpers HL, Meleth S, Grizzle WE, Manne U.

J Gastrointest Oncol. 2010 Dec;1(2):76-89. doi: 10.3978/j.issn.2078-6891.2010.019.

PMID:
22811811
[PubMed]
Free PMC Article
11.

Challenges toward personalized treatment of localized colorectal cancer.

Chen YJ, Chung V.

J Gastrointest Oncol. 2010 Dec;1(2):74-5. doi: 10.3978/j.issn.2078-6891.2010.023. No abstract available.

PMID:
22811810
[PubMed]
Free PMC Article
12.

Tumor TP53 expression status, body mass index and prognosis in colorectal cancer.

Morikawa T, Kuchiba A, Liao X, Imamura Y, Yamauchi M, Qian ZR, Nishihara R, Sato K, Meyerhardt JA, Fuchs CS, Ogino S.

Int J Cancer. 2012 Sep 1;131(5):1169-78. doi: 10.1002/ijc.26495. Epub 2011 Nov 19.

PMID:
22038927
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Molecular Prognostic and Predictive Markers in Colorectal Cancer: Current Status.

Lee JK, Chan AT.

Curr Colorectal Cancer Rep. 2011 Jun 1;7(2):136-144.

PMID:
21572547
[PubMed]
Free PMC Article
14.

The expression and prognostic impact of CXC-chemokines in stage II and III colorectal cancer epithelial and stromal tissue.

Oladipo O, Conlon S, O'Grady A, Purcell C, Wilson C, Maxwell PJ, Johnston PG, Stevenson M, Kay EW, Wilson RH, Waugh DJ.

Br J Cancer. 2011 Feb 1;104(3):480-7. doi: 10.1038/sj.bjc.6606055.

PMID:
21285972
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Translating tumor biology into personalized treatment planning: analytical performance characteristics of the Oncotype DX Colon Cancer Assay.

Clark-Langone KM, Sangli C, Krishnakumar J, Watson D.

BMC Cancer. 2010 Dec 23;10:691. doi: 10.1186/1471-2407-10-691.

PMID:
21176237
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Thymidine synthase, thymidine phosphorylase, and excision repair cross-complementation group 1 expression as predictive markers of capecitabine plus cisplatin chemotherapy as first-line treatment for patients with advanced oesophageal squamous cell carcinoma.

Lee S, Park YH, Kim KH, Cho EY, Ahn YC, Kim K, Shim YM, Ahn JS, Park K, Im YH.

Br J Cancer. 2010 Sep 7;103(6):845-51. doi: 10.1038/sj.bjc.6605831. Epub 2010 Aug 10.

PMID:
20700125
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Relationship between tumor gene expression and recurrence in four independent studies of patients with stage II/III colon cancer treated with surgery alone or surgery plus adjuvant fluorouracil plus leucovorin.

O'Connell MJ, Lavery I, Yothers G, Paik S, Clark-Langone KM, Lopatin M, Watson D, Baehner FL, Shak S, Baker J, Cowens JW, Wolmark N.

J Clin Oncol. 2010 Sep 1;28(25):3937-44. doi: 10.1200/JCO.2010.28.9538. Epub 2010 Aug 2.

PMID:
20679606
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Prognostic and predictive biomarkers in resected colon cancer: current status and future perspectives for integrating genomics into biomarker discovery.

Tejpar S, Bertagnolli M, Bosman F, Lenz HJ, Garraway L, Waldman F, Warren R, Bild A, Collins-Brennan D, Hahn H, Harkin DP, Kennedy R, Ilyas M, Morreau H, Proutski V, Swanton C, Tomlinson I, Delorenzi M, Fiocca R, Van Cutsem E, Roth A.

Oncologist. 2010;15(4):390-404. doi: 10.1634/theoncologist.2009-0233. Epub 2010 Mar 29. Review.

PMID:
20350999
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Adjuvant therapy of colon cancer: current status and future developments.

Morse MA.

Clin Colon Rectal Surg. 2005 Aug;18(3):224-31. doi: 10.1055/s-2005-916283.

PMID:
20011305
[PubMed]
Free PMC Article
20.

Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis.

Fluge Ø, Gravdal K, Carlsen E, Vonen B, Kjellevold K, Refsum S, Lilleng R, Eide TJ, Halvorsen TB, Tveit KM, Otte AP, Akslen LA, Dahl O; Norwegian Gastrointestinal Cancer Group.

Br J Cancer. 2009 Oct 20;101(8):1282-9. doi: 10.1038/sj.bjc.6605333. Epub 2009 Sep 22.

PMID:
19773751
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk